A
April Kinninger
Researcher at UCLA Medical Center
Publications - 79
Citations - 488
April Kinninger is an academic researcher from UCLA Medical Center. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 26 publications receiving 234 citations. Previous affiliations of April Kinninger include University of California, Los Angeles & Los Angeles Biomedical Research Institute.
Papers
More filters
Journal ArticleDOI
Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial.
Matthew J. Budoff,Deepak L. Bhatt,April Kinninger,Suvasini Lakshmanan,Joseph B. Muhlestein,Viet T Le,Viet T Le,Heidi T May,Kashif Shaikh,Chandana Shekar,Sion K. Roy,John A. Tayek,John R Nelson +12 more
TL;DR: Icosapent ethyl demonstrated significant regression of LAP volume on MDCT compared with placebo over 18 months, providing important mechanistic data on plaque characteristics that may have relevance to the REDUCE-IT results and clinical use of IPE.
Journal ArticleDOI
Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: a prospective, placebo-controlled randomized trial (EVAPORATE): interim results.
Matthew J. Budoff,Joseph B. Muhlestein,Deepak L. Bhatt,Viet T Le Pa,Viet T Le Pa,Heidi T May,Kashif Shaikh,Chandana Shekar,April Kinninger,Suvasini Lakshmanan,Sion K. Roy,John A. Tayek,John R Nelson +12 more
TL;DR: This study shows that most coronary plaque types show slowed rates of progression under the influence of statin plus Icosapent ethyl, and provides important mechanistic data in regards to the reduction in CV events in the REDUCE-IT clinical trial.
Journal ArticleDOI
Comparison of mineral oil and non-mineral oil placebo on coronary plaque progression by coronary computed tomography angiography.
Suvasini Lakshmanan,Chandana Shekar,April Kinninger,S. Dahal,A. Onuegbu,A. Cai,Sajad Hamal,Divya Birudaraju,Sion K. Roy,John R Nelson,Matthew J. Budoff,Deepak L. Bhatt +11 more
TL;DR: Author(s): Lakshmanan, Suvasini; Shekar, Chandana; Kinninger, April; Dahal, Suraj; Onuegbu, Afiachukwu; Cai, Andrew N; Hamal, Sajad; Birudaraju, Divya; Roy, Sion K; Nelson, John R; Budoff, Matthew J; Bhatt, Deepak L
Journal ArticleDOI
Aged garlic extract reduces low attenuation plaque in coronary arteries of patients with diabetes: A randomized, double‑blind, placebo‑controlled study
Kashif Shaikh,April Kinninger,Lavanya Cherukuri,Divya Birudaraju,Rine Nakanishi,Shone Almeida,Eranthi Jayawardena,Chandana Shekar,Ferdinand Flores,Sajad Hamal,Mohammed Salman Sheikh,Amit Johanis,Benedict Cu,Matthew J. Budoff +13 more
TL;DR: On the whole, this study indicated that the %LAP change in the AGE group was significantly greater than that in the placebo group in patients with diabetes, and further studies are warranted to evaluate whether AGE has the ability to stabilize vulnerable plaque and decrease adverse cardiovascular events.
Journal ArticleDOI
Effect of semaglutide on coronary atherosclerosis progression in patients with type II diabetes: rationale and design of the semaglutide treatment on coronary progression trial.
Sajad Hamal,Lavanya Cherukuri,Kashif Shaikh,April Kinninger,Jay Doshi,Divya Birudaraju,Matthew J. Budoff +6 more
TL;DR: The primary hypothesis of the current study is to assess the effect of semaglutide to reduce progression of noncalcified coronary atherosclerotic plaque volume as measured by serial coronary CTA as compared to placebo in persons with diabetes over 1 year.